Interní Med. 2017; 19(5): 272-273

When not to treat dyslipidemia?

MUDr. Ľubica Cibičková, Ph.D., doc. MUDr. David Karásek, Ph.D.
3. interní klinika – nefrologie, revmatologie, endokrinologie; Fakultní nemocnice Olomouc

We bring a report about clinical situations with indication to stop or not to start therapy of dyslipidemia. We discusscontraindications of treatment of hypercholesterolemia and hypertriglyceridemia.

Keywords: dyslipidemia, hypercholesterolemia, statins

Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibičková Ľ, Karásek D. When not to treat dyslipidemia? Interní Med. 2017;19(5):272-273.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Soška V. Terapie DLP. In: Poruchy metabolismu lipidů. Diagnostika a léčba. Grada, 2001; 82-86.
    2. Janský P, Rosolová H, Vrablík M. 2016 ESC/EAS Guidelines for the management of Dyslipidaemias. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2017; 59: 389-415. Go to original source...
    3. Češka R. Praktické postupy v léčbě HLD a DLP. In: Cholesterol a ateroskleróza, léčba dyslipidemií. Triton 2012; 337-353.
    4. Soška V, Vaverková H, Vrablík M, et al. Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011. Doporučené postupy. Vnitř Lék 2013; 59(2): 120-126. Go to PubMed...
    5. Rosolová H. Současný stav hypolipidemické léčby u nás. Interv Akut Kardiol 2016; 15(2): 81-84. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.